HDAC inhibitors demonstrate an anti-cancer effect via the production of reactive oxygen species, of which dampening renders the resistance to HDAC inhibitors in cancer cells, which requires future investigation to reveal the mechanism of resistance acquisition of cancer [26,27]. Here, HDAC9 is linked to cancer.